Theodore Friedmann

Last updated

Theodore Friedmann (born June 16, 1935) is an American researcher most noted for his work in human gene therapy. [1] [2]

Contents

Early life and education

He was born in Vienna. His family emigrated to the United States when he was a young child. [3] Friedmann received his A.B in 1956 and M.D. in 1960 from the University of Pennsylvania. He received an M.A. from the University of Oxford in 1995, where he was the Newton-Abraham Visiting Professor in 1996.

Career and research

After his MD, he worked at the Children's Hospital Medical Center, Boston, Massachusetts from 1960 to 1962, and the US Air Force 10th Tac. Hospital in Alconbury, England from 1962 to 1963. He then worked as a research fellow in colloid science at the University of Cambridge from 1963 to 1964 before returning to Boston, where he was also a teaching and research fellow at Harvard University. He worked at the National Institutes of Health from 1965 to 1968, and then joined the University of California, San Diego where he was assistant professor, promoted to associate professor in 1973 and professor in 1981. [4]

He is a past president of the American Society for Gene Therapy (now the American Society of Gene and Cell Therapy). [5]

He also served as the first chair of WADA's Gene Doping Expert Group, [6] from its establishment in 2004 [7] to 2019 [8]

He was awarded the Japan Prize in 2015 'for the proposal of the concept of gene therapy and its clinical applications. [9]

Awards

Selected publications

Related Research Articles

<span class="mw-page-title-main">National Institutes of Health</span> US government medical research agency

The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

Repoxygen was the tradename for a type of gene therapy to produce erythropoietin (EPO). It was under preclinical development by Oxford Biomedica as a possible treatment for anaemia but was abandoned in 2003.

<span class="mw-page-title-main">Steven Rosenberg</span> American cancer researcher

Steven A. Rosenberg is an American cancer researcher and surgeon, chief of Surgery at the National Cancer Institute in Bethesda, Maryland and a Professor of Surgery at the Uniformed Services University of Health Sciences and the George Washington University School of Medicine and Health Sciences. He pioneered the development of immunotherapy that has resulted in the first effective immunotherapies and the development of gene therapy. He is the first researcher to successfully insert foreign genes into humans.

Charles Thomas Caskey, also known as C. Thomas Caskey, was an American internist who has been a medical Geneticist and biomedical researcher and entrepreneur. He was a Professor of Molecular and Human Genetics at Baylor College of Medicine, and served as editor of the Annual Review of Medicine from 2001 to 2019. He was a member of the editorial boards of the Proceedings of the National Academy of Sciences, Science, the Encyclopedia of Molecular Medicine and numerous other medical and scientific journals.

<span class="mw-page-title-main">Ralph L. Brinster</span> American geneticist

Ralph Lawrence Brinster is an American geneticist, National Medal of Science laureate, and Richard King Mellon Professor of Reproductive Physiology at the School of Veterinary Medicine, University of Pennsylvania.

<span class="mw-page-title-main">Victor Dzau</span> Chinese-American doctor and academic

Victor Joseph Dzau is a Chinese-American doctor and academic. He serves as the President of the United States National Academy of Medicine of the United States National Academy of Sciences. He was previously the president and CEO of Duke University Medical Center.

Ajit Varki is a physician-scientist who is distinguished professor of medicine and cellular and molecular medicine, founding co-director of the Glycobiology Research and Training Center at the University of California, San Diego (UCSD), and founding co-director of the UCSD/Salk Center for Academic Research and Training in Anthropogeny (CARTA). He is also executive editor of the textbook Essentials of Glycobiology and distinguished visiting professor at the Indian Institute of Technology in Madras and the National Center for Biological Sciences in Bangalore. He is a specialist advisor to the Human Gene Nomenclature Committee.

<span class="mw-page-title-main">Francis Collins</span> American physician-scientist (born 1950)

Francis Sellers Collins is an American physician-scientist who discovered the genes associated with a number of diseases and led the Human Genome Project. He served as director of the National Institutes of Health (NIH) in Bethesda, Maryland, from 17 August 2009 to 19 December 2021, serving under three presidents.

<span class="mw-page-title-main">NIH Intramural Research Program</span> Internal research program of the National Institutes of Health

The NIH Intramural Research Program (IRP) is the internal research program of the National Institutes of Health (NIH), known for its synergistic approach to biomedical science. With 1,200 Principal Investigators and over 4,000 Postdoctoral Fellows conducting basic, translational, and clinical research, the NIH Intramural Research Program is the largest biomedical research institution on earth. The unique funding environment of the IRP facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. With rigorous external reviews ensuring that only the most outstanding research secures funding, the IRP is responsible for many scientific accomplishments, including the discovery of fluoride to prevent tooth decay, the use of lithium to manage bipolar disorder, and the creation of vaccines against hepatitis, Hemophilus influenzae (Hib), and human papillomavirus (HPV). In addition, the IRP has also produced or trained 21 Nobel Prize-winning scientists.

Inder Mohan Verma is an Indian American molecular biologist, the former Cancer Society Professor of Molecular Biology in the Laboratory of Genetics at the Salk Institute for Biological Studies and the University of California, San Diego. He is recognized for seminal discoveries in the fields of cancer, immunology, and gene therapy.

<span class="mw-page-title-main">Tasuku Honjo</span> Japanese immunologist and Nobel laureate (born 1942)

Tasuku Honjo is a Japanese physician-scientist and immunologist. He won the 2018 Nobel Prize in Physiology or Medicine and is best known for his identification of programmed cell death protein 1 (PD-1). He is also known for his molecular identification of cytokines: IL-4 and IL-5, as well as the discovery of activation-induced cytidine deaminase (AID) that is essential for class switch recombination and somatic hypermutation.

<span class="mw-page-title-main">Stefan Karlsson (professor)</span>

Stefan Karlsson is a Professor of Molecular Medicine and Gene Therapy at the Lund Stem Cell Center, in the Department of Laboratory Medicine, Lund University, Sweden. He is recognized for significant contributions to the fields of gene therapy and hematopoietic stem cell biology and in 2009 was awarded the Tobias Prize by The Royal Swedish Academy of Sciences.

<span class="mw-page-title-main">Adah Almutairi</span>

Adah Almutairi is a scientist and professor at the University of California, San Diego (UCSD). Her work focuses on nanomedicine, nanotechnology, chemistry and polymer science.

<span class="mw-page-title-main">Gary Firestein</span> American rheumatologist

Gary S. Firestein is an American rheumatologist, professor, and founding director of the Altman Clinical and Translational Research Institute (ACTRI) at the University of California San Diego and Senior Associate Vice Chancellor for Health Sciences at University of California, San Diego.

JoAnn Trejo is an American pharmacologist, cell biologist, a professor, and also an assistant vice chancellor in the department of health sciences faculty affairs in the Department of Pharmacology at the School of Medicine at University of California, San Diego. She is also the assistant vice chancellor for Health Sciences Faculty Affairs. Trejo studies cell signalling by protease-activated G protein-coupled receptors (GPCRs). She is also actively involved in mentoring, education and outreach activities to increase the diversity of science.

<span class="mw-page-title-main">Gene doping</span> Hypothetical non-therapeutic use of gene therapy by athletes

Gene doping is the hypothetical non-therapeutic use of gene therapy by athletes in order to improve their performance in those sporting events which prohibit such applications of genetic modification technology, and for reasons other than the treatment of disease. As of April 2015, there is no evidence that gene doping has been used for athletic performance-enhancement in any sporting events. Gene doping would involve the use of gene transfer to increase or decrease gene expression and protein biosynthesis of a specific human protein; this could be done by directly injecting the gene carrier into the person, or by taking cells from the person, transfecting the cells, and administering the cells back to the person.

<span class="mw-page-title-main">Drew Weissman</span> American physician and immunologist (born 1959)

Drew Weissman is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).

The Herbert Wertheim School of Public Health and Human Longevity Science (HWSPH) is the University of California, San Diego's school of public and community health. The school was founded in September 2019 following a 2018 gift from the Dr. Herbert and Nicole Wertheim Family Foundation. The school is currently led by founding Dean Cheryl A. M. Anderson, who was appointed to the position in June 2020.

<span class="mw-page-title-main">Cynthia E. Dunbar</span> American hematologist

Cynthia Dunbar is an American scientist and hematologist at the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH). She is the Branch Chief of the Translational Stem Cell Biology Branch.

<span class="mw-page-title-main">Nina F. Schor</span> American pediatric neurologist

Nina Felice Schor is an American physician-scientist and pediatric neurologist. She has served as director of the NIH Intramural Research Program since the Fall of 2022. Schor was the deputy director of National Institute of Neurological Disorders and Stroke from 2018 to 2022. She was the William H. Eilinger Chair of the Department of Pediatrics at University of Rochester and Pediatrician-in-Chief of the Golisano Children’s Hospital from 2006 to January 2018.

References

  1. "Dr. Theodore Friedmann – Gene Therapy Lab". UC San Diego. Retrieved 17 December 2019.
  2. "The Japan Prize Foundation". The Japan Prize Foundation. Retrieved 17 December 2019.
  3. "Theodore Friedmann takes on the sponsorship of wax model in the Josephinum". Medical University of Vienna. 2015-10-16. Retrieved 2022-08-12.
  4. "Alumni News – NIH Intramural Research Program". NIH Intramural Research Program. Retrieved 17 December 2019.
  5. 1 2 3 4 "UCSD Professor Named President of American Society of Gene Therapy". ucsdnews.ucsd.edu. June 26, 2006. Retrieved 2022-08-12.
  6. "play-true/play-true-magazine-gene-doping" (PDF). WADA. Retrieved 16 January 2020.
  7. "Gene Doping". WADA. Retrieved 16 January 2020.
  8. "2019 WADA EXPERT GROUPS" (PDF). WADA. Retrieved 16 January 2020.
  9. "Friedmann Recognized for Pioneering Gene Therapy Research". ucsdnews.ucsd.edu. Retrieved 2022-03-18.

PubMed search for Theodore Friedmann